Cristin-resultat-ID: 1910165
Sist endret: 28. januar 2022, 08:21
NVI-rapporteringsår: 2021
Resultat
Vitenskapelig artikkel
2021

Interventions and symptom relief in hospital palliative cancer care: results from a prospective longitudinal study

Bidragsytere:
  • Morten Thronæs
  • Erik T Løhre
  • Anne Kvikstad
  • Elisabeth Brenne
  • Robin Norvaag
  • Kathrine Othelie Aalberg
  • mfl.

Tidsskrift

Supportive Care in Cancer
ISSN 0941-4355
e-ISSN 1433-7339
NVI-nivå 1

Om resultatet

Vitenskapelig artikkel
Publiseringsår: 2021
Publisert online: 2021
Open Access

Importkilder

Scopus-ID: 2-s2.0-85105374686

Beskrivelse Beskrivelse

Tittel

Interventions and symptom relief in hospital palliative cancer care: results from a prospective longitudinal study

Sammendrag

Purpose To study the use of interventions and symptom relief for adult patients with incurable cancer admitted to an acute palliative care unit providing integrated oncology and palliative care services. Methods All admissions during 1 year were assessed. The use of interventions was evaluated for all hospitalizations. Patients with assessments for worst and average pain intensity, tiredness, drowsiness, nausea, appetite, dyspnea, depression, anxiety, well-being, constipation, and sleep were evaluated for symptom development during hospitalization. Descriptive statistics was applied for the use of interventions and the paired sample t-test to compare symptom intensities (SIs). Results For 451 admissions, mean hospital length of stay was 7.0 days and mean patient age 69 years. More than one-third received systemic cancer therapy. Diagnostic imaging was performed in 66% of the hospitalizations, intravenous rehydration in 45%, 37% received antibiotics, and 39% were attended by the multidisciplinary team. At admission and at discharge, respectively, 55% and 44% received oral opioids and 27% and 45% subcutaneous opioids. For the majority, opioid dose was adjusted during hospitalization. Symptom registrations were available for 180 patients. Tiredness yielded the highest mean SI score (5.6, NRS 0–10) at admission and nausea the lowest (2.2). Signifcant reductions during hospitalization were reported for all assessed SIs (p≤0.01). Patients receiving systemic cancer therapy reported symptom relief similar to those not on systemic cancer therapy. Conclusion Clinical practice and symptom relief during hospitalization were described. Symptom improvements were similar for oncological and palliative care patients.

Bidragsytere

Morten Thronæs

  • Tilknyttet:
    Forfatter
    ved Institutt for klinisk og molekylær medisin ved Norges teknisk-naturvitenskapelige universitet
  • Tilknyttet:
    Forfatter
    ved Kreftklinikken ved St. Olavs Hospital HF

Erik Torbjørn Løhre

Bidragsyterens navn vises på dette resultatet som Erik T Løhre
  • Tilknyttet:
    Forfatter
    ved Kreftklinikken ved St. Olavs Hospital HF
  • Tilknyttet:
    Forfatter
    ved Institutt for klinisk og molekylær medisin ved Norges teknisk-naturvitenskapelige universitet

Anne Kvikstad

  • Tilknyttet:
    Forfatter
    ved Kreftklinikken ved St. Olavs Hospital HF
  • Tilknyttet:
    Forfatter
    ved Institutt for klinisk og molekylær medisin ved Norges teknisk-naturvitenskapelige universitet

Elisabeth Brenne

  • Tilknyttet:
    Forfatter
    ved Kreftklinikken ved St. Olavs Hospital HF
  • Tilknyttet:
    Forfatter
    ved Institutt for klinisk og molekylær medisin ved Norges teknisk-naturvitenskapelige universitet

Robin Norvaag

  • Tilknyttet:
    Forfatter
    ved Kreftklinikken ved St. Olavs Hospital HF
1 - 5 av 11 | Neste | Siste »